Robert S. Benjamin

Peer-Reviewed Articles

1. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2022. PMID: 36151848.
2. Moyers JT, Pestana RC, Roszik J, Hong DS, Naing A, Fu S, Piha-Paul S, Yap TA, Karp D, Rodon J, Livingston A, Zarzour MA, Ravi V, Patel S, Benjamin RS, Ludwig J, Herzog C, Ratan R, Somaiah N, Conley A, Gorlick R, Meric-Bernstam F, Subbiah V. Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102). Clin Cancer Res 29(2):401-409, 2023. e-Pub 2022. PMID: 36288393.
3. Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
4. Stacchiotti S, Maria Frezza A, Demetri GD, Blay JY, Bajpai J, Baldi GG, Baldini EH, Benjamin RS, Bonvalot S, Bovée JVMG, Callegaro D, Casali PG, D'Angelo SP, Davis EJ, Dei Tos AP, Demicco EG, Desai J, Dileo P, Eriksson M, Gelderblom H, George S, Gladdy RA, Gounder MM, Gupta AA, Haas R, Hayes A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Maestro R, Martin Broto J, Maki RG, Miah AB, Palmerini E, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Strauss SJ, Tap WD, Thomas DM, Trama A, Trent JC, van der Graaf WTA, van Houdt WJ, von Mehren M, Wilky BA, Fletcher CDM, Gronchi A, Miceli R, Wagner AJ. Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments. Cancer Treat Rev 110:102455, 2022. e-Pub 2022. PMID: 36031697.
5. Qian J, Kubicki SL, Curry JL, Jahan-Tigh R, Benjamin R, Heberton M, Nelson KC. Pembrolizumab-induced rash in a patient with angiosarcoma. JAAD Case Rep 29:21-24, 2022. e-Pub 2022. PMID: 36186410.
6. Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, Mennel RG, Bishop AJ, Sturgis EM, Goepfert RP, Yalamanchili S, Botello G, Stephen B, Piha-Paul SA, Patel AB, Lazar AJ, Conley AP, Benjamin RS, Patel SR, Futreal PA, Somaiah N, Naing A. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer 128(18):3383-3391, 2022. e-Pub 2022. PMID: 35792683.
7. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
8. Benjamin RS. There is more to soft tissue sarcomas than just grade and size. Cancer 128(1):28-29, 2022. e-Pub 2021. PMID: 34643940.
9. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
10. Patel RR, Lupo PJ, Bishop AJ, Lin PP, Delclos GL, Lazar AJ, Benjamin RS, Araujo DM. Synovial Sarcoma of the Hand and Foot: An Institutional Review. Am J Clin Oncol 44(7):361-368, 2021. e-Pub 2021. PMID: 33927134.
11. Benjamin RS, Minotti G. Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to Cardioprotection. Clin Cancer Res 27(14):3809-3811, 2021. e-Pub 2021. PMID: 33990361.
12. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
13. Frezza AM, Ravi V, Lo Vullo S, Vincenzi B, Tolomeo F, Chen TW, Teterycz P, Baldi GG, Italiano A, Penel N, Brunello A, Duffaud F, Hindi N, Iwata S, Smrke A, Fedenko A, Gelderblom H, Van Der Graaf W, Vozy A, Connolly E, Grassi M, Benjamin RS, Broto JM, Grignani G, Jones RL, Kawai A, Tysarowski A, Mariani L, Casali PG, Stacchiotti S. Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature. Cancer Med 10(8):2645-2659, 2021. e-Pub 2021. PMID: 33713582.
14. Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, Ludwig JA. IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32630797.
15. Wu CC, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang WL, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA. Immuno-genomic landscape of osteosarcoma. Nat Commun 11(1):1008, 2020. e-Pub 2020. PMID: 32081846.
16. Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, Noguchi E, Siontis B, Ferraro R, Teterycz P, Duffaud F, Ravi V, Vincenzi B, Gelderblom H, Pantaleo MA, Baldi GG, Desar I, Fedenko A, Maki RG, Jones RL, Benjamin RS, Blay JY, Kawai A, Gounder M, Gronchi A, Le Cesne A, Mir O, Czarnecka AM, Schuetze S, Wagner AJ, Adam J, Barisella M, Sbaraglia M, Hornick JL, Meurgey A, Mariani L, Casali PG, Thornton K, Stacchiotti S. Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network. Cancer 126(1):98-104, 2020. e-Pub 2019. PMID: 31536651.
17. Benjamin RS. Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective. Adv Exp Med Biol 1257:1-10, 2020. PMID: 32483726.
18. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
19. Chrisinger JSA, Al-Zaid T, Keung EZ, Leung C, Lin HY, Roland CL, Torres KE, Benjamin RS, Ingram DR, Khan S, Somaiah N, Amini B, Feig BW, Lazar AJ, Wang WL. The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum. J Surg Oncol 120(3):382-388, 2019. e-Pub 2019. PMID: 31206726.
20. Subbiah V, Anderson PM, Kairemo K, Hess K, Huh WW, Ravi V, Daw NC, Somaiah N, Ludwig JA, Benjamin RS, Chawla S, Hong DS, Meric-Bernstam F, Ravizzini G, Kleinerman E, Macapinlac H, Rohren E. Alpha particle Radium 223 dichloride in high-risk osteosarcoma: a phase I dose escalation trial. Clin Cancer Res 25(13):3802-3810, 2019. e-Pub 2019. PMID: 30733229.
21. Subbiah V, Lamhamedi-Cherradi SE, Cuglievan B, Menegaz BA, Camacho P, Huh W, Ramamoorthy V, Anderson PM, Pollock RE, Lev DC, Qiao W, McAleer MF, Benjamin RS, Patel S, Herzog CE, Daw NC, Feig BW, Lazar AJ, Hayes-Jordan A, Ludwig JA. Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clin Cancer Res 24(19):4865-4873, 2018. e-Pub 2018. PMID: 29871905.
22. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick JL, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne SL, Sbaraglia M, Thway K, Wagrodzki M, Wang WL, Yoshida A, Mariani L, Kawai A, Stacchiotti S. Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series. JAMA Oncol 4(9):e180219, 2018. e-Pub 2018. PMID: 29800950.
23. Subbiah V, Murthy R, Hong DS, Prins RM, Hosing C, Hendricks K, Kolli D, Noffsinger L, Brown R, McGuire M, Fu S, Piha-Paul S, Naing A, Conley AP, Benjamin RS, Kaur I, Bosch ML. Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers. Clin Cancer Res 24(16):3845-3856, 2018. e-Pub 2018. PMID: 30018119.
24. von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, Morris ZS, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Ruo B, Schuetze S, Tap WD, Wayne JD, Bergman MA, Scavone JL. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(5):536-563, 2018. PMID: 29752328.
25. Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW. The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center. J Surg Oncol. e-Pub 2018. PMID: 29723411.
26. Beird HC, Wu CC, Ingram DR, Wang WL, Alimohamed A, Gumbs C, Little L, Song X, Feig BW, Roland CL, Zhang J, Benjamin RS, Hwu P, Lazar AJ, Futreal PA, Somaiah N. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Cold Spring Harb Mol Case Stud 4(2), 2018. e-Pub 2018. PMID: 29610390.
27. Menegaz BA, Cuglievan B, Benson J, Camacho P, Lamhamedi-Cherradi SE, Leung CH, Warneke CL, Huh W, Subbiah V, Benjamin RS, Patel S, Daw N, Hayes-Jordan A, Ludwig JA. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor. Oncologist 23(3):360-366, 2018. e-Pub 2017. PMID: 29212731.
28. Groisberg R, Hong DS, Behrang A, Hess K, Janku F, Piha-Paul S, Naing A, Fu S, Benjamin R, Patel S, Somaiah N, Conley A, Meric-Bernstam F, Subbiah V. Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials. J Immunother Cancer 5(1):100, 2017. e-Pub 2017. PMID: 29254498.
29. Dembla V, Groisberg R, Hess K, Fu S, Wheler J, Hong DS, Janku F, Zinner R, Piha-Paul SA, Ravi V, Benjamin RS, Patel S, Somaiah N, Herzog CE, Karp DD, Roszik J, Meric-Bernstam F, Subbiah V. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Sci Rep 7(1):15963, 2017. e-Pub 2017. PMID: 29162825.
30. Livingston JA, Bugano D, Barbo A, Lin H, Madewell JE, Wang WL, Lazar AJ, Tseng WW, Roland CL, Feig BW, Pollock R, Conley AP, Benjamin RS, Patel S, Somaiah N. Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Sci Rep 7(1):11836, 2017. e-Pub 2017. PMID: 28928422.
31. Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Sci Rep 7(1):9519, 2017. e-Pub 2017. PMID: 28842575.
32. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. Oncologist. e-Pub 2017. PMID: 28710342.
33. Abu Saleh WK, Ramlawi B, Shapira OM, Al Jabbari O, Ravi V, Benjamin R, Durand JB, Leja MJ, Blackmon SH, Bruckner BA, Reardon MJ. Improved Outcomes With the Evolution of a Neoadjuvant Chemotherapy Approach to Right Heart Sarcoma. Ann Thorac Surg 104(1):90-96, 2017. e-Pub 2017. PMID: 28189277.
34. Groisberg R, Hong DS, Holla V, Janku F, Piha-Paul S, Ravi V, Benjamin R, Kumar Patel S, Somaiah N, Conley A, Ali SM, Schrock AB, Ross JS, Stephens PJ, Miller VA, Sen S, Herzog C, Meric-Bernstam F, Subbiah V. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas. Oncotarget 8(24):39254-39267, 2017. PMID: 28424409.
35. Benjamin RS. Observational studies: goldmines of information on rare diseases. BMC Med 15(1):100, 2017. e-Pub 2017. PMID: 28494808.
36. Farag S, Somaiah N, Choi H, Heeres B, Wang WL, van Boven H, Nederlof P, Benjamin R, van der Graaf W, Grunhagen D, Boonstra PA, Reyners AK, Gelderblom H, Steeghs N. Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients. Eur J Cancer 76:76-83, 2017. e-Pub 2017. PMID: 28284172.
37. Benjamin RS. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: a personal point of view. Tumori:0. e-Pub 2017. PMID: 28430348.
38. Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, Didwania A, Fabbri N, Hornicek FJ, Kuechle JB, Lindskog D, Mayerson J, McGarry SV, Million L, Morris CD, Movva S, O'Donnell RJ, Randall RL, Rose P, Santana VM, Satcher RL, Schwartz H, Siegel HJ, Thornton K, Villalobos V, Bergman MA, Scavone JL. NCCN Guidelines Insights: Bone Cancer, Version 2.2017. J Natl Compr Canc Netw 15(2):155-167, 2017. PMID: 28188186.
39. Heinrich M, Rankin C, Blanke CD, Demetri GD, Borden EC, Ryan CW, von Mehren M, Blackstein ME, Priebat DA, Tap WD, Maki RG, Corless CL, Fletcher JA, Owzar K, Crowley JJ, Benjamin RS, Baker LH. Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. JAMA Oncol. e-Pub 2017. PMID: 28196207.
40. Gopalakrishnan V, Amini B, Wagner MJ, Nowell EN, Lazar AJ, Lin PP, Benjamin RS, Araujo DM. Synovial Sarcoma of the Head and Neck: A Single Institution Review. Sarcoma 2017:2016752, 2017. e-Pub 2017. PMID: 28655993.
41. Chen LL, Zhu J, Schumacher J, Wei C, Ramdas L, Prieto VG, Jimenez A, Velasco MA, Tripp SR, Andtbacka RHI, Gouw L, Rodgers GM, Zhang L, Chan BK, Cassidy PB, Benjamin RS, Leachman SA, Frazier ML. SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions. PLoS One 12(9):e0184154, 2017. e-Pub 2017. PMID: 28880927.
42. Quintana RA, Banchs J, Gupta R, Lin HY, Raj SD, Conley A, Ravi V, Araujo D, Benjamin RS, Patel S, Vadhan-Raj S, Somaiah N. Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion. Sarcoma 2017:7495914, 2017. e-Pub 2017. PMID: 29081684.
43. Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JA. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. J Natl Cancer Inst 108(12), 2016. e-Pub 2016. PMID: 27576731.
44. Subbiah V, Hess KR, Khawaja MR, Wagner MJ, Tang C, Naing A, Fu S, Janku F, Piha-Paul S, Tsimberidou AM, Herzog CE, Ludwig JA, Patel S, Ravi V, Benjamin RS, Meric-Bernstam F, Hong DS. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Sci Rep 6:35448, 2016. e-Pub 2016. PMID: 27748430.
45. Kumar R, Meis JM, Amini B, McEnery KW, Madewell JE, Rhines LD, Benjamin RS. Giant Cell Tumor of Cervical Spine Presenting as Acute Asphyxia: Successful Surgical Resection after Down-staging with Denosumab. Spine (Phila Pa 1976). e-Pub 2016. PMID: 27792106.
46. Benjamin RS, Futreal A. Are sarcomas hereditary?. Lancet Oncol. e-Pub 2016. PMID: 27498912.
47. Livingston JA, Hess KR, Naing A, Hong DS, Patel S, Benjamin RS, Ludwig JA, Conley A, Herzog CE, Anderson P, Meric-Bernstam F, Kurzrock R, Subbiah V. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget. e-Pub 2016. PMID: 27486883.
48. von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14(6):758-86, 2016. PMID: 27283169.
49. Etchebehere EC, Hobbs BP, Milton DR, Malawi O, Patel S, Benjamin RS, Macapinlac HA. Assessing the role of (18)F-FDG PET and (18)F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 43(5):860-70, 2016. e-Pub 2015. PMID: 26631240.
50. Wagner MJ, Livingston JA, Patel SR, Benjamin RS. Chemotherapy for Bone Sarcoma in Adults. J Oncol Pract 12(3):208-16, 2016. PMID: 26962160.
51. Varghese M, Bruland O, Wiedswang AM, Lobmaier I, Røsok B, Benjamin RS, Hall KS. Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature. Clin Sarcoma Res 6:2, 2016. e-Pub 2016. PMID: 26913180.
52. Gupta R, Heshami N, Jay C, Ramesh N, Song J, Lei X, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Predictors of survival in patients with sarcoma admitted to the intensive care unit. Clin Sarcoma Res 6:12, 2016. e-Pub 2016. PMID: 27437097.
53. Benjamin RS, Casali PG. Adjuvant Imatinib for GI Stromal Tumors: When and For How Long?. J Clin Oncol. e-Pub 2015. PMID: 26644523.
54. Ramlawi B, Leja MJ, Abu Saleh WK, Al Jabbari O, Benjamin R, Ravi V, Shapira OM, Blackmon SH, Bruckner BA, Reardon MJ. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience. Ann Thorac Surg. e-Pub 2015. PMID: 26476808.
55. Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol 32(2):105-11, 2015. e-Pub 2014. PMID: 25388523.
56. Ravi V, Patel S, Benjamin RS. Chemotherapy for soft-tissue sarcomas. Oncology (Williston Park) 29(1):43-50, 2015. PMID: 25592207.
57. Benjamin RS. Osteosarcoma: better treatment through better trial design. Lancet Oncol 16(1):12-3, 2015. e-Pub 2014. PMID: 25638539.
58. Benjamin RS, Wagner MJ, Livingston JA, Ravi V, Patel SR. Chemotherapy for bone sarcomas in adults: the MD anderson experience. Am Soc Clin Oncol Educ Book 35:e656-60, 2015. PMID: 25993237.
59. Khoury M, Sim GC, Harao M, Radvanyi L, Amini B, Benjamin RS, Pisters PW, Pollock RE, Tseng WW. Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management. BMJ Case Rep 2015, 2015. e-Pub 2015. PMID: 26156843.
60. Joseph J, Wang WL, Patnana M, Ramesh N, Benjamin R, Patel S, Ravi V. Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma. Clin Sarcoma Res 5:22, 2015. e-Pub 2015. PMID: 26500758.
61. El-Sayed Ahmed MM, Aftab M, Al-Najjar RM, de la Cruz KI, Benjamin RS, Hallman CH. Pulmonary artery sarcoma mimicking pulmonary embolism. Tex Heart Inst J 41(5):515-7, 2014. e-Pub 2014. PMID: 25425986.
62. Ramlawi B, Al-Jabbari O, Blau LN, Davies MG, Bruckner BA, Blackmon SH, Ravi V, Benjamin R, Rodriguez L, Shapira OM, Reardon MJ. Autotransplantation for the resection of complex left heart tumors. Ann Thorac Surg 98(3):863-8, 2014. e-Pub 2014. PMID: 25086947.
63. Roberts NJ, Zhang L, Janku F, Collins A, Bai RY, Staedtke V, Rusk AW, Tung D, Miller M, Roix J, Khanna KV, Murthy R, Benjamin RS, Helgason T, Szvalb AD, Bird JE, Roy-Chowdhuri S, Zhang HH, Qiao Y, Karim B, McDaniel J, Elpiner A, Sahora A, Lachowicz J, Phillips B, Turner A, Klein MK, Post G, Diaz LA, Riggins GJ, Papadopoulos N, Kinzler KW, Vogelstein B, Bettegowda C, Huso DL, Varterasian M, Saha S, Zhou S. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med 6(249):249ra111, 2014. PMID: 25122639.
64. Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin RS, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijfer S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) . Ann Oncol. e-Pub 2014. PMID: 25070543.
65. von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H. Gastrointestinal stromal tumors, version 2.2014. J Natl Compr Canc Netw 12(6):853-62, 2014. PMID: 24925196.
66. Benjamin RS, Lee JJ. One step forward, two steps back. Lancet Oncol 15(4):366-7, 2014. PMID: 24694628.
67. von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, Delaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H, National Comprehensive Cancer Network. Soft tissue sarcoma, version 2.2014. J Natl Compr Canc Netw 12(4):473-83, 2014. PMID: 24717567.
68. Zhang YP, Myers AL, Trinh VA, Kawedia JD, Kramer MA, Benjamin RS, Tran HT. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. J Oncol Pharm Pract 20(1):58-64, 2014. e-Pub 2013. PMID: 23676513.
69. Jiang Y, Subbiah V, Janku F, Ludwig JA, Naing A, Benjamin RS, Brown RE, Anderson P, Kurzrock R. Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors. PLoS One 9(8):e93676, 2014. e-Pub 2014. PMID: 25119929.
70. Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC. Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. Cancer Med 2(4):553-63, 2013. e-Pub 2013. PMID: 24156028.
71. Biermann JS, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow W, Curry WT, Frassica DA, Frassica FJ, Hande KR, Hornicek FJ, Jones RL, Mayerson J, McGarry SV, McGrath B, Morris CD, O'Donnell RJ, Randall RL, Santana VM, Satcher RL, Siegel HJ, von Mehren M, Bergman MA, Sundar H, National complrehensive cancer network. Bone cancer. J Natl Compr Canc Netw 11(6):688-723, 2013. PMID: 23744868.
72. Jiang Y, Janku F, Subbiah V, Angelo LS, Naing A, Anderson PM, Herzog CE, Fu S, Benjamin RS, Kurzrock R. Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications. Oncotarget 4(6):884-9, 2013. PMID: 23800680.
73. Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM, Benjamin RS. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 24(1):257-63, 2013. e-Pub 2012. PMID: 22910841.
74. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res 3(1):7, 2013. e-Pub 2013. PMID: 23663788.
75. Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, Benjamin RS, Vadhan-Raj S. Prognostic Significance of Elevated D-Dimer for Survival in Patients with Sarcoma. Am J Clin Oncol 35(5):462-7, 2012. e-Pub 2011. PMID: 21654313.
76. von Mehren M, Benjamin RS, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S, Gonzalez R, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Paz B, Pfeifer JD, Pollock RE, Randall RL, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Shankar S, Van Tine BA, Wayne J, Sundar H, McMillian NR. Soft Tissue Sarcoma, Version 2.2012: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw 10(8):951-960, 2012. PMID: 22878820.
77. Dumont SN, Lazar AJ, Bridge JA, Benjamin RS, Trent JC. PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization. J Cancer Res Clin Oncol 138(2):213-20, 2012. e-Pub 2011. PMID: 22089931.
78. Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ. Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. Oncologist 17(3):321, 2012. e-Pub 2012. PMID: 22363068.
79. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res 2(1):25, 2012. e-Pub 2012. PMID: 23272660.
80. Pappo AS, Patel SR, Crowley J, Reinke DK, Kuenkele KP, Chawla SP, Toner GC, Maki RG, Meyers PA, Chugh R, Ganjoo KN, Schuetze SM, Juergens H, Leahy MG, Geoerger B, Benjamin RS, Helman LJ, Baker LH. R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research through Collaboration Study. J Clin Oncol. e-Pub 2011. PMID: 22025149.
81. Benjamin RS, Schöffski P, Hartmann JT, Van Oosterom A, Bui BN, Duyster J, Schuetze S, Blay JY, Reichardt P, Rosen LS, Skubitz K, McCoy S, Sun YN, Stepan DE, Baker L. Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors. Cancer Chemother Pharmacol 68(1):69-77, 2011. e-Pub 2010. PMID: 20838998.
82. Wray CJ, Benjamin RS, Hunt KK, Cormier JN, Ross MI, Feig BW. Isolated limb perfusion for unresectable extremity sarcoma: Results of 2 single-institution phase 2 trials. Cancer 117(14):3235-41, 2011. e-Pub 2011. PMID: 21246524.
83. Ewer MS, Von Hoff DD, Benjamin RS. A historical perspective of anthracycline cardiotoxicity. Heart Fail Clin 7(3):363-72, 2011. e-Pub 2011. PMID: 21749888.
84. Ludwig JA, Lamhamedi-Cherradi SE, Lee HY, Naing A, Benjamin R. Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance. Cancers (Basel) 3(3):3029-54, 2011. e-Pub 2011. PMID: 24212944.
85. Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 212(5):821-6, 2011. e-Pub 2011. PMID: 21435923.
86. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. e-Pub 2011. PMID: 21480200.
87. Subbiah V, Naing A, Brown RE, Chen H, Doyle L, LoRusso P, Benjamin R, Anderson P, Kurzrock R. Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures. PLoS One 6(4):e18424, 2011. e-Pub 2011. PMID: 21494688.
88. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med 153(6):358-67, 2010. PMID: 20855800.
89. Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer 115(14):3262-70, 2009. e-Pub 2009. PMID: 19382187.
90. Chugh R, Wathen JK, Maki RG, Benjamin RS, Patel SR, Meyers PA, Myers PA, Priebat DA, Reinke DK, Thomas DG, Keohan ML, Samuels BL, Baker LH. Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model. J Clin Oncol 27(19):3148-53, 2009. e-Pub 2009. PMID: 19451433.
91. Chen LL, Holden JA, Choi H, Zhu J, Wu FF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stomal tumor correlates wth the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21(7):826-36, 2008. e-Pub 2008. PMID: 18488000.
92. Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26(4):626-32, 2008. PMID: 18235122.
93. Benjamin RS. SARC-CTOS imaging symposium: introduction to the problem from a clinical perspective. Oncologist 13 Suppl 2:1-3, 2008. PMID: 18434630.
94. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol 25(19):2755-63, 2007. PMID: 17602081.
95. Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C. We Should Desist Using RECIST, at Least in GIST. J Clin Oncol 25(13):1760-1764, 2007. PMID: 17470866.
96. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25(13):1753-9, 2007. PMID: 17470865.
97. Benjamin RS, Blanke CD, Blay JY, Bonvalot S, Eisenberg B. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies. Oncologist 11(1):9-20, 2006. PMID: 16401709.
98. Chawla SP, Benjamin RS. Effectiveness of chemotherapy in the management of metastatic telangiectatic osteosarcoma. Am J Clin Oncol 11(2):177-80, 1988. PMID: 3162788.
99. Shin DM, Gupta V, Donner L, Chawla S, Benjamin R, Gutterman J, Blick M. Aberrant oncogene expression in uncultured human sarcoma and melanoma. Anticancer Res 7(6):1117-23, 1987. PMID: 3442409.
100. Raymond AK, Chawla SP, Carrasco CH, Ayala AG, Fanning CV, Grice B, Armen T, Plager C, Papadopoulos NE, Edeiken J. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 4(3):212-236, 1987. PMID: 3313606.
101. Benjamin RS. Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma?. J Clin Oncol 5(6):833-5, 1987. PMID: 3295127.
102. Edeiken J, Raymond AK, Ayala AG, Benjamin RS, Murray JA, Carrasco HC. Small-cell osteosarcoma. Skeletal Radiol 16(8):621-8, 1987. PMID: 3321462.
103. Weber RS, Benjamin RS, Peters LJ, Ro JY, Achon O, Goepfert H. Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 152(4):386-92, 1986. PMID: 3766868.
104. Ajani JA, Dimery I, Chawla SP, Pinnamaneni K, Benjamin RS, Legha SS, Krakoff IH. Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomas. Cancer Treat Rep 70(3):375-9, 1986. PMID: 3955548.
105. Souba WW, McKenna RJ, Jr, Meis J, Benjamin R, Raymond AK, Mountain CF. Radiation-induced sarcomas of the chest wall. Cancer 57(3):610-5, 1986. PMID: 3942997.
106. Benjamin RS. Limb salvage surgery for sarcomas: a good idea receives formal blessing. Jama 254(13):1795-6, 1985. PMID: 3861878.
107. Benjamin RS, Chawla SP, Ewer MS, Carrasco CH, Mackay B, Holmes F. Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update. Invest New Drugs 3(2):117-21, 1985. PMID: 4019116.
108. Kurzrock R, Yap BS, Plager C, Papdopoulos N, Benjamin RS, Valdivieso M, Bodey GP. Phase II evaluation of PALA in patients with refractory metastatic sarcomas. Am J Clin Oncol 7(4):305-7, 1984. PMID: 6741860.
109. Yap BS, Benjamin RS, Plager C, Burgess MA, Papadoupoulos N, Bodey GP. A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas. Am J Clin Oncol 6(2):235-8, 1983. PMID: 6829497.
110. Jaffe N, Knapp J, Chuang VP, Wallace S, Ayala A, Murray J, Cangir A, Wang A, Benjamin RS. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies. Cancer 51(3):402-7, 1983. PMID: 6571796.
111. Zidar BL, Benjamin RS, Frank J, Lane M, Baker LH. Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study. Am J Clin Oncol 6(1):71-4, 1983. PMID: 6837508.
112. Chuang VP, Benjamin R, Jaffe N, Wallace S, Ayala AG, Murray J, Charnsangavej C, Soo CS. Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR Am J Roentgenol 139(6):1065-9, 1982. PMID: 6756101.
113. Ryan JR, Baker LH, Benjamin RS. The natural history of metastatic synovial sarcoma: experience of the Southwest Oncology group. Clin Orthop Relat Res(164):257-60, 1982. PMID: 6279348.
114. Yap BS, Benjamin RS, Burgess MA, Murphy WK, Sinkovics JG, Bodey GP. A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adults. Cancer 47(12):2807-9, 1981. PMID: 7260872.
115. Bodey GP, Rodriguez V, Murphy WK, Burgess A, Benjamin RS. Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy. Cancer 47(10):2422-9, 1981. PMID: 7272896.
116. Yap BS, Plager C, Benjamin RS, Murphy WK, Legha SS, Bodey GP. Phase II evaluation of AMSA in adult sarcomas. Cancer Treat Rep 65(3-4):341-3, 1981. PMID: 6263473.
117. Chuang VP, Wallace S, Benjamin RS, Jaffe N, Ayala A, Murray J, Zornoza J, Patt Y, Mavligit G, Charnsangavej C, Soo CS. The therapy of osteosarcoma by intraarterial cis-platinum an limb preservation. Cardiovasc Intervent Radiol 4(4):229-35, 1981. PMID: 6948613.
118. Bedikian AY, Khankhanian N, Valdivieso M, Heilbrun LK, Benjamin RS, Yap BS, Nelson RS, Bodey GP. Sarcoma of the stomach: clinicopathologic study of 43 cases. J Surg Oncol 13(2):121-7, 1980. PMID: 7359919.
119. Stewart DJ, McCredie KD, Barlogie B, Valdivieso M, Benjamin RS, Burgess MA, Bodey GP. Phase I study of 3-deazauridine in the treatment of adults with solid tumors. Cancer Treat Rep 64(12):1295-9, 1980. PMID: 7471119.
120. Yap BS, Baker LH, Sinkovics JG, Rivkin SE, Bottomley R, Thigpen T, Burgess MA, Benjamin RS, Bodey GP. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 64(1):93-8, 1980. PMID: 7379060.
121. Samson MK, Baker LH, Benjamin RS, Lane M, Plager C. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study. Cancer Treat Rep 63(11-12):2027-9, 1979. PMID: 575067.
122. Bedikian AY, Valdivieso M, Khankhanian N, Benjamin RS, Bodey GP. Chemotherapy for sarcoma of the stomach. Cancer Treat Rep 63(3):411-4, 1979. PMID: 427823.
123. Benjamin RS, Baker LH, O'Bryan RM, Moon TE, Gottlieb JA. Chemotherapy for metastic osteosarcoma--studies by the M.D. Anderson Hospital and the Southwest Oncology Group. Cancer Treat Rep 62(2):237-8, 1978. PMID: 273476.
124. Thigpen JT, O'Bryan RM, Benjamin RS, Coltman CA. Phase II trial of Baker's antifol in metastatic sarcoma. Cancer Treat Rep 61(8):1485-7, 1977. PMID: 922752.
125. Benjamin RS, Baker LH, O'Bryan RM, Moon TE, Gottlieb JA. Advances in the chemotherapy of soft tissue sarcomas. Med Clin North Am 61(5):1039-43, 1977. PMID: 895246.
126. Gottlieb JA, Benjamin RS, Baker LH, O'Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Bodey GP, Rodriguez V, Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sullivan P, Thigpen T, Bottomley R, Balcerzak S, Moon TE. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep 60(2):199-203, 1976. PMID: 769974.
127. Benjamin RS, Wiernik PH, Bachur NR. Adriamycin: a new effective agent in the therapy of disseminated sarcomas. Med Pediatr Oncol 1(1):63-76, 1975. PMID: 1232527.
128. Benjamin RS. Pharmacokinetics of adriamycin (NSC-123127) in patients with sarcomas. Cancer Chemother Rep 58(2):271-3, 1974. PMID: 4830501.
129. Benjamin RS, Wiernik PH, Bachur NR. Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer 33(1):19-27, 1974. PMID: 4810094.

Invited Articles

1. Trent JC, Benjamin RS. New Developments in Gastrointestinal Stromal Tumor. Curr Opin Oncol:386-395, 2006.
2. Benjamin RS. Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma. J Clin Oncol 5:833-835, 1987.
3. Murray, JA, Jessup K, Romsdahl M, Raymond K, Ayala A, Carrasco H, Wallace S, Jaffe N, Benjamin RS, Plager C, Papadopoulos N, Chawla S. Limb-salvage surgery in osteosarcoma: early experience at M.D. Anderson Hospital and Tumor Institute. Cancer Treat Symp 3:131-137, 1985.
4. Benjamin RS, Chawla SP, Ewer MS, Carrasco CH, Mackay B, Holmes F. Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update. Invest New Drug 3:117-121, 1985.
5. Benjamin RS, Holmes F, Chawla SP, Ewer MS, Carrasco CH, Mackay B, Dukart G, Bodey GP. Evaluation of novantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update. Proceedings of the Current Status of Novantron:69-73, 1985.
6. Benjamin RS. Limb salvage surgery for sarcomas: a good idea receives formal blessing. JAMA 254:1795-1796, 1985.
7. Benjamin RS, Murray JA, Wallace S, Ayala A, Chawla SP, Raymond AK, Carrasco CH, Romsdahl MM, Papadopoulos NEJ, Plager C. Intra-arterial preoperative chemotherapy for osteosarcoma--a judicious approach to limb salvage. Cancer Bull 36:32-36, 1984.
8. Benjamin RS, Lindberg RD, Martin RG, Murray J, Wallace S, Chuang VP, Ayala A, Romsdahl MM. Limb salvage for patients with sarcoma of soft tissue and bone. Cancer Bull 35:11-15, 1983.
9. Benjamin RS. Update on chemotherapy of soft-tissue and bone sarcoma. Mediguide to Oncology (ed, Wiernick PH) New York, DellaCorte Pub:1-7, 1982.
10. Benjamin RS, Baker LH, O'Bryan RM, Moon TE, Gottlieb JA. Chemotherapy of metastatic osteosarcoma - studies by the M.D. Anderson Hospital and the Southwest Oncology Group. Cancer Treat Rep 62:237-238, 1978.
11. Gottlieb JA, Benjamin RS, Baker LH, O’Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Godey GP, Rodriguez V, Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sullivan P, Thigpen T, Bottomley R, Balcerzak S, Moon TE. Role of DTIC (NSC 45388) in the chemotherapy of sarcomas. Cancer Treat Rep(60):199-203, 1976.
12. Benjamin RS. A practical approach to adriamycin (NSC 123127) toxicology. Cancer Chemother Rep 6:191-194, 1975.
13. Benjamin RS. Pharmacokinetics of adriamycin (NSC 123127) in patients with sarcoma. Cancer Chemother Rep(58):271-273, 1974.

Editorials

1. Patel SR, Benjamin RS. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol 24(1):11-12, 2006. PMID: 16330666.

Abstracts

1. Thirasastr P, Joseph C, Araujo DM, Benjamin RS, Conley AP, Livingston JA, Ludwig JA, Patel SR, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Outcomes in late-line systemic treatment in GISTs: Does sequence matter?. 2022 Annual ASCO Meeting, 2022.
2. Michael Nakazawa, J Andrew Andrew Livingston, Andrew Justin Bishop, Maria Alejandra Zarzour, Neeta Somaiah, Ravin Ratan, Jonathan Benjamin Gill, Elizabeth Urquiola, Kristi Posey, Beverly Ashleigh Guadagnolo, Richard Greg Gorlick, Robert S. Benjamin, Shreyaskumar Patel, Anthony Paul Conley. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma (ARMS) patients on front-line therapies: An MD Anderson Cancer Center (MDACC) case series. ASCO. 2022 Annual ASCO Meeting, 2022.
3. Thirasastr P, Behrang Amini, Heather Lin, Christina L. Roland, Elise F. Nassif, Alejandra Zarzour, Anthony P. Conley, Dejka M. Araujo, Emily Z. Keung, J Andrew Livingston, Ravin Ratan, Joseph A. Ludwig, IV, Robert S Benjamin, Xiao Zhou, Shreyaskumar Patel, Vinod Ravi, Barry W. Feig, Neeta Somaiah. Retrospective Evaluation Of The Role Of Gemcitabine- Docetaxel In Well-Differentiated And Dedifferentiated Liposarcoma. 2021 Annual CTOS Virtual Meeting, 2021.
4. Akash Mitra, Neeta Somaiah, Anthony P. Conley, Behrang Amini, Heather Lin, Beatriz E. Sanchez, Celia Garcia-Prieto, Grace Mathew, Chantale Bernatchez, Vinod Ravi, Dejka Araujo, Maria A. Zarzour, John A. Livingston, Christina L. Roland, Najat Daw, Joshua Baguley, Wei-Lien Wang, Hannah Beird, Taylor Tate, Cara Haymaker, Latasha D. Little, Curtis Gumbs, Xingshi Song, Emily Z. Keung, Shaojun Zhang, Swati Gite, Jianhua Zhang, Luisa Solis, Hussein Tawbi, Linghua Wang, Shreyaskumar Patel, Robert S. Benjamin, Alexander J. Lazar, Ignacio I. Wistuba, Andrew Futreal. Immunogenomic correlates of response to combination immune checkpoint blockade in advanced sarcoma. 2021 AACR Annual Meeting, 2021.
5. Somaiah N, Conley AP, Lin HY, Amini A, Sabir SH, Araujo DM, Benjamin RS, Livingston JA, Patel S, Ratan R, Ravi V, Zarzour MA, Wang WL, Tate t, Roland RL, Daw NC, Futreal A, Wistuba I,. Phase II Multi-arm Study of Durvalumab and Tremelimumab for Advanced or Metastatic Sarcomas. 2020 Annual ASCO Virtual Meeting, 2020.
6. Subramaniam A, Zheng J, Yalamanchili S, Conley AP, Ratan R, Somaiah N, Livingston JA, Zarzour MA, Araujo DM, Benjamin RS, Patel SR, Ravi V. Modulation of YAP by statins to Improve Survival in Epitheloid hemangioendothelioma (EHE). 2020 Annual ASCO Virtual Meeting, 2020.
7. Groisberg R, Hong D, Holla V, Janku F, Piha-Paul S, Ravi S, Benjamin R. Patel S, Somaiah N, Conley A, Ali Siraj, Schrock A, Ross J, Stephens P, Miller V, Sen S. Herzog C, Meric-Bernstam F, Subbiah V. Clinical genomic profiling to identify actionable alterations for investigarional therapies in patients with diferser sarcomas. Ann Oncol, 2020.
8. Parkes AM, Patel S, Leung CH, Lin HY, Conley AP, Somaiah N, Araujo DM, Zarzour MA, Livingston JA, Ravi V, Benjamin RS, Ratan R. Systemic therapy regimen outcomes in metastatic phyllodes tumors of the breast. J. Clin Oncol 36, 2018.
9. Somaiah N, Conley A, Espiridion BS, Lin H, Amini B, Ravi V, Araujo D, Benjamin R, Patel S, Zarzour A, Sabir S, Lazar AJ, Wang WL, Wistuba II. A phase II multi-arm study to test the efficacy of durvalumab and tremelimumab in multiple sarcoma subtypes. CTOS 2017 Annual Meeting, 2017.
10. Livingston JA, Posey K, Subbiah V, Daw JC, Somaiah N, Ravi V, Patel S, Benjamin RS, Wang WL, Lazar A, Broaddus R, Meric-Bernstam F, Shaw KR, Roszik J, Conley AP. Analysis of osteosarcoma subtypes by clinical genomic testing to identify clinically actionable alterations. Journal of Clincal Oncology, 2017.
11. Conley AP, Livingston JA, Ravi V, Shaw KR, Subbiah V, Janku F, Broaddus R, Lewis V, Patel S, Benjamin R, Wang WL, Lazar A, Futreal A, Meric-Bernstam F, Roszik J. Assessment of next generation sequencing (NGS) for patients with chondrosarcoma. CTOS 2017 Annual Meeting, 2017.
12. Conley AP, Huh WW, Roszik J, Harrison DJ, Hayes-Jordan AA, Kehr KA, Ratan R, Ravi V, Arauo DM, Zarzour MA, Ludwig JA, Wang WL, Benjamin RS, Patel S. Clinical characteristics of adult alveolar rhabdomyosarcoma (ARMS) patients (Pts) on front-line therapies: An MD Anderson Cancer Center (MDACC) series. J Clin Oncol, 2016.
13. Groisberg R, Hong DS, Janku F, Piha-Paul SA, Ravi V, Benjamin RS, Patel S, Somaiah N, Conley AP, Herzog CE, Meric-Bernstam F, Subbiah V. Clinical next generation sequencing in sarcomas. J Clin Oncol, 2016.
14. Nathenson M, Conley AP, Ratan R, Zarzour MA, Somaiah N, Araujo DM, Patel S, Benjamin RS, Ravi V. Efficacy of front-line chemotherapy for recurrent/metastatic adenosarcoma of the uterus. J Clin Oncol, 2016.
15. Conley AP, Satcher Rl, Wang WL, Lazar AJF, Fox PS, Lin PP, Moon B, Bird JE, Araujo DM, Ravi V, Somaiah N, Patel S, Benjamin RS, Lewis VO. Clinical Characteristics and treatment outcomes of clear cell chondrosarcomas. J Clin Oncol, 2015.
16. Vadhan-Raj S, Ravi V, Zhou X, Araujo DM, Somaiah N, Conley AP, Daniel M, Benjamin RS, Patel S, Spasojevic I. Effects of fosaprepitan (Fosa) on ifosfamide (Ifex) metabolism in sarcoma patients (pts) receiving multi-day chemotherapy (CT) regimen on doxorubicin (Dox) and Ifex (AI): Randomized, cross-over study. J Clin Oncol, 2015.
17. Somaiah N, Berid H, Shaw KR, Wang WL, Conley AP, Ravi V, Torress KE, Ingram D, Roland CL, Subbiah V, Feig BW, Lazar AJF, Benjamin RS, Patel S, Hwu P, Futreal A, Meric-Bernstam F, Hong DS. Targeted next generation sequencing in well-differentiated/dedifferentiated liposrcoma (WD/DD LPS): Multiple gene amplifications but few mutations. J Clin Oncol, 2015.
18. Vadhan-Raj S, Araujo DM, Trent JC, Zhou X, Ludwig JA, Ravi V, Chambers MS, Patel S, Benjamin RS. Phase II study of caphosol oral rinse for prevention of oral mucositis (OM) in sarcoma patiens (pts) receiving multi-cycle doxorubicin-based chemotherapy (CT): Randomized study with cross-over to palifermin for severe OM. ASCO 2012 Annual Mtg. Chicago, Illinois (#92822), 2012.
19. Subbiah V, Viny AD, Anderson PM, Hayes-Jordan A, Qiao W, Benjamin RS, Maki RG, Ludwig JA. Optimizing the therapy of desmoplastic small round cell tumor: Combined experience from the two major cancer centers. Journal of Clinical Oncology, 2012 ASCO Annual Meeting Proceedings 30(No. 15S):Abstract 10021, 2012.
20. Park MS, Patel S, Ravi V, Conley AP, Trent JC, Lazar AJF, Lev D, Wang X, Benjamin RS, Araujo, DM. The role of chemotherapy in advanced hemangiopericyoma/solitary fibrous tumor. Journal of Clinical Oncology 29(15S):Abstract No. 10097, 2011.
21. Ravi V, Yang J, Araujo DM, Park MS, Benjamin RS, Zhang W, Trent JC, Patel S. The role of E-cadherin expression in response and outcome in patients with leiomyosarcoma treated with chemotherapy. Journal of Clinical Oncology 29(15S):Abstract No 10096, 2011.
22. Dumont SN, Trent JC, Patel SR, Araujo DM, Dumont AG, Benjamin RS. A phase II study of low-dose protracted irinotecan in patients with advanced sarcomas. Journal of Clinical Oncology, 2011 ASCO Annual Meeting Proceedings 29(15_suppl):Abstract 10064, 2011.
23. S. Stacchiotti; R. Benjamin; J.Y. Blay; I. Judson; A. Le Cesne; R. Maki; E. Palassini; S. Patel; P. Rutkowski; I. Ray-Coquard; M. Scurr; J. Trent; V. Ravi; P.G. Casali. SUNITINIB IN ADVANCED ALVEOLAR SOFT PART SARCOMA (ASPS): A MULTI-INSTITUTIONAL RETROSPECTIVE CASE SERIES ANALYSIS WITHIN THE WORLD SARCOMA NETWORK. 2010 CTOS Annual Meeting(Abstract 893840), 2010.
24. V. Subbiah; A.M. Tsimberidou; A. Naing; J.C. Trent; D.S. Hong; P.M. Anderson; R. Benjamin; R. Kurzrock. THE M. D. ANDERSON CANCER CENTER EXPERIENCE WITH EARLY PHASE CLINICAL TRIALS IN SARCOMA PATIENTS. 2010 CTOS Annual Meeting(Abstract 900287), 2010.
25. Benjamin RS, Blanke CD, Blay JY, Bonvalot S, Eisenberg B. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies. Oncologist 11(1):9-20, 2006.
26. Patel SR, Benjamin RS. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J. Clin Oncol 24(1):11-2, 2005. e-Pub 2005.

Book Chapters

1. Patel SR, Benjamin RS. Soft Tissue and Bone Sarcomas and Bone Metastases. In: Harrison's Priniples of Internal Medicine. 18th. McGraw-Hill Companies, Inc, 817-821, 2011.
2. Benjamin, RS, Chawla SP, Carrasco C, Raymond AK, Fanning T, Wallace S, Ayala AG, Murray J. Arterial infusion in the treatment of osteosarcoma. In: Recent Concepts in Sarcoma Treatment . Kluwer Academic Publishers, 269-274, 1988.
3. Benjamin RS. Chemotherapy for osteosarcoma. In: Bone Tumors . Churchill Livingston, 149-156, 1988.
4. Benjamin RS. Soft tissue sarcomas. In: Handbook of Cancer Chemotherapy. Little, Brown and Company, 557-565, 1987.
5. Benjamin RS. Bony sarcomas. In: Handbook of Cancer Chemotherapy. Little, Brown and Company, 203-208, 1987.
6. Benjamin, RS, Terjanian TO, Fenoglio CJ, Barkley HT, Evans HL, Murphy WK, Martin RG. The importance of combination chemotherapy for adjuvant treatment of high-risk patients with soft-tissue sarcomas of the extremities. In: Adjuvant Therapy of Cancer V . Grune & Stratton, 735-744, 1987.
7. Chawla, SP, Benjamin RS, Jaffe N, Carrasco CH, Raymond AK AG, Wallace S, Armen T, Papadopoulos NEJ, Plager C, Murray JA. Preoperative intra-arterial cisplatin and limb-salvage surgery for patients with high-grade osteosarcoma of the extremities. In: Adjuvant Therapy of Cancer V . Grune & Stratton, 701-710, 1987.
8. Benjamin RS. Soft tissue sarcomas. In: Comprehensive Textbook of Oncology . Williams & Wilkins, 659-662, 1986.
9. Benjamin, RS, Chawla SP, Hortobagyi GN, Ewer MS, Mackay B, Legha SS, Carrasco H, Wallace S. Continuous-infusion adriamycin. . In: Clinical Applications of Continuous Infusion Chemotherapy and Concomitant Radiation Therapy . Plenum Press, 19-25, 1986.
10. Benjamin, RS, Chawla SP, Carrasco CH, Raymond AK, Murray JA, Wallace S, Ayala A, Papadopoulos NEJ, Plager C, Romsdahl MM, Martin RG. Primary chemotherapy for osteosarcoma - implications for limb salvage and ultimate prognosis. . In: Neo-adjuvant Chemotherapy - First International Congress. John Libby Eurotext, 557-565, 1986.
11. Benjamin, RS, Chawla SP, Ewer MS, Carrasco CH, Mackay B, Haynie TP, Yap HY, Blumenschein GR, Holmes F, Ali MK, Bodey GP. Mitoxantrone cardiotoxicity: evaluation by nuclear angiography and endomyocardial biopsy. In: Pharmanual. Sieber & McIntyre, 49-56, 1984.
12. Benjamin, RS, Murray JA, Carrasco CH, Raymond AK, Chawla SP, Wallace S, Ayala A, Papadopoulos NEJ, Plager C, Romsdahl MM. Preoperative chemotherapy for osteosarcoma: a treatment approach facilitating limb salvage with major prognostic implications. In: Adjuvant Therapy of Cancer IV . Grune & Stratton, 601-610, 1984.
13. Chawla, SP, Benjamin RS, Abdul-Karim FW, Ayala AG, Papadopoulos NEJ, Plager C, Romsdahl M, Jaffe N, Murray JA. Adjuvant chemotherapy of primary malignant fibrous histiocytoma of bone - prolongation of disease-free and overall survival. In: Adjuvant Therapy of Cancer IV . Grune & Stratton, 621-629, 1984.
14. Benjamin, RS, Yap BS. Infusion chemotherapy for soft tissue sarcomas. In: Soft Tissue Sarcoma . Martinus Nijhoff, 109-115, 1983.
15. Chawla, SP, Benjamin RS, Legha SS, Ewer MS, Ali ML, Mackay B, Carrasco CH, Hortobagyi GN, Wallace S, Haynie III TP, Freireich EJ. Role of cardiac biospy and radionuclide scan in monitoring of adriamycin-induced cardiotoxicity. In: 13th International Congress of Chemotherapy, 490-492, 1983.
16. Benjamin RS. Adjuvant chemotherapy for osteosarcoma. In: Controversies in Onoclogy. John Wiley & Sons, 175-187, 1982.
17. Benjamin RS. Soft tissue sarcomas. In: Manual of Cancer Chemotherapy . Little, Brown, and Company, 151-154, 1982.
18. Benjamin RS. Bony sarcomas. In: Manual of Cancer Chemotherapy . Little, Brown, and Company, 155-160, 1982.
19. Legha, SS, Benjamin RS, Mackay B, Ewer MS, Blumenschein G. Role of adriamycin in breast cancer and sarcomas. In: Anthracycline Antibiotics in Cancer Therapy. Martinue Nijhoff, 432-444, 1982.
20. Benjamin RS. The sarcomas. In: Cancer and Chemotherapy. Academic Press, 275-293, 1981.
21. Loo, TL, Savaraj N, Lu K, Yap BS, Yap HY, Benjamin RS. Clinical pharmacokinetics of vindesine. Current Chemotherapy and Immunotherapy. In: Proc 12th Internat’l Congr of Chemotherapy, 1981.
22. Ayala, AG, Mackay B, Jaffe N, Sutow W, Benjamin RS, Murray JA. Osteosarcoma: the pathological study of specimens from en bloc resection in patients receiving preoperative chemotherapy. In: Status of the Curability of Childhood Cancer. Raven Press, 127-144, 1980.
23. Stewart, DJ, Benjamin RS, Baker LH, Yap BS, Bodey GP. New drugs for the treatment of soft tissue sarcoma. In: Therapeutics Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas. Martinus Nijhoff Publ, 453-480, 1980.
24. Benjamin, RS, Baker LH, O'Bryan RM, Moon TE, Gottlieb JA. Advances in the chemotherapy of soft-tissue sarcomas. In: Medical Clinic of North American. WB Sander, 1039-1043, 1977.
25. Benjamin, RS, Baker LH, Rodriquez V, Moon TE, O’Bryan RM, Stephens RL, Sinkovics JG, Thigpen T, King GW, Bottomley R, Groppe CW, Bodey GP, Gottlieb JA. The chemotherapy of soft-tissue sarcomas in adults. In: Management of Primary Bone and Soft Tissue Tumor . Year Book Medical Publisher, 309-315, 1977.
26. Lindbergh RD, Murphy WK, Benjamin RS, Sinkovics JG, Martin RG, Romsdahl MM, Jesse RH, Russel WO. Adjuvant chemotherapy in the treatment of primary soft-tissue sarcomas - a preliminary report. In: Management of Primary Bone Tumor and Soft Tissue Tumors. Year Book Medical Publishing, 343-352, 1977.
27. Murphy WK, Benjamin RS, Eyre HJ, Thigpen T, Whitecar JP, Uribe-Bkotero G, Baker LH, Gehan EA, Gottlieb JA. Adjuvant chemotherapy in osteosarcoma of adults. A Southwest Oncology Group Study. In: Adjuvant Therapy of Cancer. North Holland Press, 399-406, 1977.
28. Thigpen T, Groppe C, Uribe-Botero G, Baker LH, Gehan EA, Gottlieb JA. Update: adjuvant chemotherapy in osteosarcoma of adults - SWOG Carter. In: Cancer Chemother Rep, 83-397, 1975.

Letters to the Editor

1. Benjamin RS. Reply - Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma. J Clin Oncol 6: 183-184, 1988.